These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6112245)

  • 21. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R
    Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind randomized trial of the benzodiazepine derivative metaclazepam as compared with placebo treatment of outpatients with anxiety syndromes.
    Laakmann G; Blaschke D; Hippius H; Schewe S
    Pharmacopsychiatry; 1988 May; 21(3):136-43. PubMed ID: 2900514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
    Ansseau M; Ansoms C; Beckers G; Bogaerts M; Botte L; De Buck R; Diricq S; Dumortier A; Jansegers E; Owieczka J
    J Affect Disord; 1984 Dec; 7(3-4):287-96. PubMed ID: 6151958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report of alprazolam-induced stuttering.
    Elliott RL; Thomas BJ
    J Clin Psychopharmacol; 1985 Jun; 5(3):159-60. PubMed ID: 2860135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alprazolam (Tafil) and bromazepam (Lexotan) in the treatment of anxiety. A randomized, double-blind comparison in psychiatric outpatients].
    Sonne LM; Bruun-Hansen J
    Ugeskr Laeger; 1986 Jun; 148(23):1392-5. PubMed ID: 2873673
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression.
    Singh AN; Nair NP; Suranyi-Cadotte B; Schwartz G; Lizondo E
    Can J Psychiatry; 1988 Apr; 33(3):218-22. PubMed ID: 3289717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alprazolam compared to clobazam and placebo in anxious outpatients.
    Castillo A; Sotillo C; Mariategui J
    Neuropsychobiology; 1987; 18(4):189-94. PubMed ID: 2900483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression.
    Imlah NW
    Br J Psychiatry; 1985 May; 146():515-9. PubMed ID: 2861873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double-blind controlled trial comparing alprazolam and lorazepam in ambulatory anxious patients].
    Hecquet S; Puech AJ; Lecrubier Y
    Therapie; 1984; 39(3):253-61. PubMed ID: 6147031
    [No Abstract]   [Full Text] [Related]  

  • 35. Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial.
    Stein DJ
    Adv Ther; 2015 Jan; 32(1):57-68. PubMed ID: 25620535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
    Möller HJ; Volz HP; Reimann IW; Stoll KD
    J Clin Psychopharmacol; 2001 Feb; 21(1):59-65. PubMed ID: 11199949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alprazolam (Xanax).
    Med Lett Drugs Ther; 1982 Apr; 24(607):41-2. PubMed ID: 6123071
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the therapeutic effect, tolerance and safety of ketazolam and diazepam administered for six months to out-patients with chronic anxiety neurosis.
    Fabre LF; McLendon DM; Stephens AG
    J Int Med Res; 1981; 9(3):191-8. PubMed ID: 6113174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled study on the anxiolytic activity of a newly-developed benzodiazepine, metaclazepam.
    Marano P; Patti F; Nicoletti F
    Curr Med Res Opin; 1988; 11(1):41-4. PubMed ID: 2898320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
    Goodman WK; Charney DS; Price LH; Woods SW; Heninger GR
    Am J Psychiatry; 1986 Jul; 143(7):900-3. PubMed ID: 2872826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.